natgillin/translations-raw huggingface dataset:
In 2016, vaccination coverage for diphtheria, tetanus and pertussis among children in the EU was below the required 95%, and there is still a need to ensure continued protection in adulthood, particularly travellers, older people, as well as those with social connections to endemic countries.
Leta 2016 je bila precepljenost proti davici, tetanusu in oslovskem kašlju med otroki v EU pod zahtevano stopnjo 95 %, še vedno pa je treba zagotavljati tudi nadaljnje varstvo pri odraslih, zlasti popotnikih, starejših in tistih z družbenimi vezmi v endemičnih državah.
This Communication presents a framework for actions to be undertaken by the Commission, with the collaboration of Member States, under three key pillars 1) tackling vaccine hesitancy and improving vaccination coverage; 2) sustainable vaccination policies in the EU; 3) EU coordination and contribution to global health.
To sporočilo predstavlja okvir za ukrepe Komisije v sodelovanju z državami članicami v okviru treh ključnih stebrov: 1) odprava nezaupanja v cepljenje in izboljšanje precepljenosti; 2) trajnostne politike cepljenja v EU; 3) usklajevanje na evropski ravni in prispevanje k zdravju na svetovni ravni.
Strengthen the effective application of Union rules on protection of healthcare workers, in particular by ensuring adequate training of healthcare workers, monitoring their immunisation status and actively offering vaccination where necessary;
okrepitev učinkovite uporabe pravil Unije o varstvu zdravstvenih delavcev, zlasti z zagotavljanjem ustreznega usposabljanja zdravstvenih delavcev, spremljanjem njihovega statusa imunizacije ter po potrebi aktivnim zagotavljanjem priložnosti za cepljenje;
Develop evidence-based tools and guidance at EU level in order to support countries to anticipate, pre-empt or respond to crises situations.
razvoj orodij, ki temeljijo na dokazih, in smernic na ravni EU v podporo državam pri predvidevanju kriznih razmer, njihovem preprečevanju ali odzivanju nanje.
It is one of the most cost-effective public health interventions, a mainstay of prevention programmes worldwide, and the elective primary prevention measure against infectious diseases.
Gre za enega najbolj stroškovno učinkovitih javnozdravstvenih ukrepov, temelj preventivnih programov po celem svetu in primarni preprečevalni ukrep proti nalezljivim boleznim.
Identify the barriers to access and support interventions to increase access to vaccination for disadvantaged and socially excluded groups;
opredelitev ovir za dostop in podpiranje ukrepov za povečanje dostopa do cepljenja za prikrajšane in socialno izključene skupine;
In addition, the rapid spread of disinformation, understood as verifiably false or misleading information, through online media make sifting science facts from unfounded claims a real challenge for those seeking trustworthy information on vaccines.
Poleg tega je zaradi hitrega širjenja dezinformacij, ki so preverljivo lažne ali zavajajoče, prek spletnih medijev ločevanje znanstvenih dejstev od neutemeljenih trditev postalo velik izziv za vse, ki iščejo zanesljive informacije o cepivih.
Regardless of the differences, all immunisation schedules have been shown to achieve their objective of disease prevention provided there is a high and timely uptake.
Ne glede na razlike pa vsi razporedi imunizacije dosežejo zastavljene cilje preprečevanja bolezni, če je precepljenost zadostna in pravočasna.
At the same time, recent events of shortages and discontinued supply of traditional vaccines have hampered the effective delivery of routine childhood immunisation programmes.
Hkrati so nedavni primeri pomanjkljive in prekinjene preskrbe s tradicionalnimi cepivi ovirali učinkovito izvajanje rutinskih programov otroške imunizacije.
Develop common methodologies to assess the relative effectiveness of vaccines, including as part of the EU cooperation on Health Technology Assessment;
razvoj skupnih metodologij za vrednotenje relativne učinkovitosti cepiv, tudi v okviru evropskega sodelovanja pri vrednotenju zdravstvenih tehnologij;
Combat the spread of disinformation in the digital era and counter disinformation spread across borders;
boj proti širjenju dezinformacij v digitalni dobi ter preprečevanje čezmejnega širjenja dezinformacij;
Strengthen partnerships and collaboration with international actors and initiatives, such as the World Health Organisation and its Strategic Advisory Group on Immunization (SAGE), the European Technical Advisory Group of Experts on Immunization (ETAGE), the Global Health Security Initiative, Global Health Security Agenda, UNICEF and financing and research initiatives like GAVI The Vaccine Alliance and the Coalition for epidemic preparedness innovations (CEPI) and the Global Research Collaboration for Infectious Diseases Preparedness (GloPID-R)
krepitev partnerstev in sodelovanja z mednarodnimi akterji in pobudami, kot so Svetovna zdravstvena organizacija in njena strateška svetovalna skupina za imunizacijo (Strategic Advisory Group on Immunization - SAGE), evropska tehnična svetovalna skupina strokovnjakov za imunizacijo (European Technical Advisory Group of Experts on Immunization - ETAGE), pobuda za globalno zdravstveno varnost (Global Health Security Initiative), agenda za globalno zdravstveno varnost (Global Health Security Agenda), UNICEF ter pobude za financiranje in raziskave, kot so partnerstvo Gavi, The Vaccine Alliance, koalicija za inovacije na področju pripravljenosti na epidemije (Coalition for epidemic preparedness innovations - CEPI) in globalno raziskovalno sodelovanje za pripravljenost na nalezljive bolezni (Global Research Collaboration for Infectious Diseases Preparedness - GloPID-R).
Strengthen the monitoring of vaccine uptake across all age groups, including healthcare workers, according to common guidance and methodologies, and share such data at EU level;
okrepitev spremljanja precepljenosti za vse starostne skupine, vključno z zdravstvenimi delavci, v skladu s skupnimi smernicami in metodologijami, ter izmenjava teh podatkov na ravni EU;
In addition to efficient record keeping, a comprehensive electronic immunisation information system in Member States can provide large data banks to strengthen the sustainability and performance of vaccination programmes.
Poleg učinkovitega vodenja evidenc lahko celovit elektronski informacijski sistem za imunizacijo v državah članicah zagotovi velike podatkovne baze za okrepitev trajnosti in učinkovitosti programov cepljenja.
At EU level this diversity may however lead to difficulties for citizens and healthcare workers in resuming vaccination when moving across borders.
Vendar lahko na ravni EU te razlike povzročijo težave državljanom in zdravstvenim delavcem pri nadaljevanju cepljenja, kadar se ti preselijo v drugo državo.
Develop guidance to overcome legal/technical barriers to interoperability and linkages with the broader healthcare system infrastructure;
priprava smernic za odpravljanje pravnih/tehničnih ovir za interoperabilnost in povezanost s širšo infrastrukturo zdravstvenega sistema;
Directive 2000/54/EC on the protection of workers from risks related to biological agents and Directive 2010/32/EU implementing the Framework Agreement on prevention from sharp injuries in the hospital and healthcare sector concluded by HOSPEEM and EPSU lay down minimum requirements to ensure healthcare workers' protection, including the need to offer vaccines to those not previously immunised.
Direktiva 2000/54/ES o varovanju delavcev pred tveganji, povezanimi z biološkimi dejavniki, in Direktiva 2010/32/EU o izvajanju okvirnega sporazuma o preprečevanju poškodb z ostrimi pripomočki v bolnišnicah in zdravstvenem sektorju, ki sta ga sklenila HOSPEEM in EPSU, določata minimalne zahteve za zagotavljanje varovanja zdravstvenih delavcev, vključno s potrebo po zagotavljanju možnosti cepljenja za osebe, ki niso bile imunizirane.
This involves removing legal, financial or structural barriers to improve equity in access, but also considering the expansion of points to deliver vaccination, such as through community-based services, which include nurses, pharmacies or school-based programmes.
To vključuje odpravljanje pravnih, finančnih in strukturnih ovir za izboljšanje enakosti dostopa, pa tudi razmislek o povečanju števila lokacij za cepljenje, na primer prek skupnostnih storitev, ki vključujejo medicinske sestre, lekarne ali šolske programe.
Strengthen the efficiency and consistency of decision making on vaccines/vaccination policies by facilitating technical cooperation between public health authorities in support of the work conducted by National Immunisation Technical Advisory Groups and affiliated bodies;
okrepitev učinkovitosti in skladnosti pri sprejemanju odločitev o cepivih/politikah cepljenja s spodbujanjem tehničnega sodelovanja med javnozdravstvenimi organi, ki podpirajo delo nacionalnih tehničnih svetovalnih skupin za imunizacijo ter povezanih organov;
Such differences may be at the expense of the quality of vaccination records, and may at times pose practical issues in the effective documentation of immunisation history, but also in the communication between different providers within and across countries.
Te razlike lahko negativno vplivajo na kakovost zapisov o cepljenju in lahko občasno povzročijo praktične težave pri učinkovitem dokumentiranju predhodne imunizacije ter komunikaciji različnih izvajalcev med državami in znotraj njih.
This cooperation will increase synergies between vaccination and related policies, including those on crisis preparedness, e-health, Health Technology Assessment, R&D and pharmaceutical industry.
To sodelovanje bo okrepilo sinergije med politikami cepljenja in sorodnimi politikami, vključno s politikami pripravljenosti na krize, e-zdravja, vrednotenja zdravstvenih tehnologij, raziskav in razvoja ter farmacevtske industrije.
Equally, there are no operational structures to enhance EU cooperation in order to address vaccine challenges, including the current fragmented vaccine research and development landscape.
Prav tako ni operativnih struktur za krepitev evropskega sodelovanja, da bi se obravnavali izzivi, povezani s cepivi, vključno s sedanjimi razdrobljenimi raziskavami in razvojem na področju cepiv.
Continuous training of all healthcare workers during their studies and once in professional practice is a priority in order to build a confident healthcare workforce that can advise the public on vaccination needs and deliver immunisation effectively.
Stalno usposabljanje vseh zdravstvenih delavcev med šolanjem in nato na delovnem mestu je prednostna naloga za zagotovitev zdravstvene delovne sile z zaupanjem v cepljenje, ki lahko javnosti svetuje o potrebah po cepljenju in učinkovito imunizira.
Convene a Coalition for Vaccination to bring together European associations of healthcare workers to commit to delivering accurate information to the public, combating myths and exchanging best practice;
sklic koalicije za cepljenje, ki bo povezala evropska združenja zdravstvenih delavcev, za zagotavljanje točnih informacij javnosti, ovržbo mitov in izmenjavo dobre prakse;
Mechanisms for better preparedness, detection and response against vaccine preventable health threats, linking to EU preparedness planning and the implementation of the International Health Regulations should include provisions to ensure support to poorer countries, particularly in cases of emergency.
Mehanizmi za boljšo pripravljenost na nevarnosti za zdravje, ki jih je mogoče preprečiti s cepljenjem, njihovo odkrivanje in odzivanje nanje, ki se povezujejo z načrtovanjem pripravljenosti EU in izvajanjem Mednarodnega zdravstvenega pravilnika, bi morali vsebovati določbe, ki zagotavljajo podporo revnejšim državam, zlasti v nujnih primerih.
As regards vaccine research and development, innovative approaches and novel vaccines are needed to better address the unmet public health needs and specific target group needs.
Kar zadeva raziskave in razvoj na področju cepiv, so za boljšo obravnavo neizpolnjenih potreb javnega zdravstva in potreb posebnih ciljnih skupin potrebni inovativni pristopi in nova cepiva.
In the pre-licensing phase, EU collaborative approaches can improve the qualitative and quantitative efficiency of the decision-making process while maintaining a strong and coordinated network of national vaccine experts.
V obdobju pred izdajo dovoljenja se lahko s skupnim pristopom EU izboljša kvalitativna in kvantitativna učinkovitost postopka sprejemanja odločitev, hkrati pa zagotovi močna in usklajena mreža nacionalnih strokovnjakov na področju cepljenja.
The World Health Organisation estimates that, today, vaccines save between 1 and 3 million lives every year, and in the coming decade vaccines are projected to save 25 million more people.
Svetovna zdravstvena organizacija (v nadaljnjem besedilu: SZO) ocenjuje, da cepiva dandanes vsako leto rešijo med enim in tremi milijoni življenj, v prihodnjem desetletju pa naj bi rešila še dodatnih 25 milijonov ljudi.
The primary forum for this coordination is the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), a network that includes nearly 30 research funders as well as the WHO and the Coalition for Epidemic Preparedness Innovations (CEPI) as observers.
Glavni forum za to usklajevanje je globalno raziskovalno sodelovanje za pripravljenost na nalezljive bolezni (GloPID-R), mreža, ki vključuje skoraj 30 financerjev raziskav in SZO ter koalicijo za inovacije na področju pripravljenosti na epidemije (CEPI) v vlogi opazovalcev.
Hesitancy is a growing concern in Europe and worldwide, which risks undermining the public health value of vaccination.
Nezaupanje povzroča vse večjo zaskrbljenost v Evropi in svetu, saj ogroža vrednost cepljenja za javno zdravje.
Develop EU guidance for establishing comprehensive electronic immunisation information systems for effective monitoring of immunisation programmes;
priprava smernic EU za vzpostavitev celovitih elektronskih informacijskih sistemov za imunizacijo za učinkovito spremljanje programov cepljenja;
Establish partnerships and research infrastructures, including for clinical trials, facilitating early dialogue with developers, public health organisations and regulators to support the authorisation of innovative vaccines, including for emerging health threats;
vzpostavitev partnerstev in raziskovalne infrastrukture, med drugim za klinično preskušanje, da se omogoči zgodnji dialog z razvijalci, javnozdravstvenimi organizacijami in regulativnimi organi v podporo izdaji dovoljenj za inovativna cepiva, vključno s cepivi proti nastajajočim nevarnostim za zdravje;
Vaccine hesitancy is highly specific to the context, country, and type of vaccine, and the public perception of a given vaccine can change rapidly.
Nezaupanje v cepljenje je v veliki meri odvisno od razmer, države in vrste cepiva, javno mnenje o določenem cepivu pa se lahko hitro spremeni.
Furthermore, ageing, mobility of people, and the shift in the burden of traditional vaccine-preventable diseases from childhood to later years of life call for a careful assessment of the cost-effectiveness of a life-course approach to vaccination.
Poleg tega staranje, mobilnost ljudi ter prenos bremena tradicionalnih bolezni, ki jih je mogoče preprečiti s cepljenjem, iz otroštva v poznejša leta zahtevajo natančno oceno stroškovne učinkovitosti vseživljenjskega pristopa k cepljenju.
Develop operational opportunities at EU level, such as the European Vaccination Information Sharing system, to increase coordination on relevant vaccination activities
razvoj operativnih priložnosti na ravni EU, kot je evropski sistem za izmenjavo informacij o cepljenju, za večjo usklajenost zadevnih dejavnosti cepljenja;
Recent fatal cases of diphtheria in the EU have also reminded that individuals who are not immunised against diseases rarely seen remain at risk.
Nedavni smrtni primeri davice v EU so nas opomnili, da so posamezniki, ki niso imunizirani proti redkim boleznim, še vedno izpostavljeni tveganju.
In recent years, the G7 and G20 have addressed global health including health security.
V zadnjih letih je bilo svetovno zdravje, vključno z zdravstveno varnostjo, obravnavano v skupinah G7 in G20.
Vaccination is an area which could receive further political impetus if addressed by these groups.
Če bosta ti skupini cepljenje obravnavali tudi v prihodnje, bi bilo to področje lahko deležno nadaljnje politične spodbude.
Vaccine hesitancy in Europe can also be driven by issues related to the affordability, geographical accessibility, or availability of information on immunisation.
Razlog za nezaupanje v cepljenje v Evropi so lahko tudi težave, povezane s cenovno in geografsko dostopnostjo ali razpoložljivostjo informacij o imunizaciji.
There is a strong need for better global preparedness against communicable diseases, and the impact of strong immunisation programmes in the EU and worldwide is key to the success of the International Health Regulations.
Nujno potrebna je boljša pripravljenost na nalezljive bolezni v svetovnem merilu, vpliv dobrih programov imunizacije v EU in po svetu pa je bistven za uspešno izvajanje Mednarodnega zdravstvenega pravilnika.
Improving access to high-quality objective and transparent information on vaccines and vaccination, including on effectiveness and safety aspects, is crucial.
Ključnega pomena je izboljšanje dostopa do visokokakovostnih objektivnih in preglednih informacij o cepivih in cepljenju, vključno z njegovo učinkovitostjo in varnostjo.
Any encounter with the healthcare system should be used as an opportunity for catch-up vaccinations to close immunity gaps.
Vse stike z zdravstvenim sistemom bi bilo treba izkoristiti kot priložnost za naknadno cepljenje za odpravo nezadostne imunizacije.
As a result, vaccination schedules vary between Member States on aspects such as timing, doses administered, type of healthcare workers involved in the delivery and vaccine purchasing practices.
Posledično se v državah članicah razlikujejo določeni vidiki cepljenja, kot so časovni razporedi, odmerki, tip zdravstvenih delavcev, ki izvajajo cepljenje, in prakse javnega naročanja.
PILLAR I - Tackling vaccine hesitancy and improving vaccination coverage
STEBER I - Odprava nezaupanja v cepljenje in izboljšanje precepljenosti
Improve access to objective and transparent information on vaccines and their safety, following the assessment of information needs on the part of both public and healthcare workers;
izboljšanje dostopa do objektivnih in preglednih informacij o cepivih ter njihovi varnosti, ko se ocenijo informacijske potrebe javnosti in tudi zdravstvenih delavcev;
They may not understand the rationale for different policies across countries, raising doubts on the scientific base for the decision-making of vaccination policies.
Morda bodo zaradi različnih nacionalnih politik začeli dvomiti o znanstveni osnovi za sprejemanje odločitev v zvezi s politikami cepljenja.
EU action should allow the standardisation of tools and methodologies to assess and report on coverage data across all ages, beyond the traditional paediatric age group, leveraging, in particular, the potential of electronic immunisation information systems.
Ukrepi EU bi morali omogočiti standardizacijo orodij in metodologij za ovrednotenje in sporočanje podatkov o precepljenosti za vsa starostna obdobja, ne le tradicionalne pediatrične starostne skupine, pri čemer bi zlasti izboljšali potencial elektronskih informacijskih sistemov za imunizacijo.
There are also technical bottlenecks which span the entire product development pipeline, and novel adjuvants are needed for vaccines for which conventional formulations have failed.
Obstajajo tudi tehnična ozka grla, ki zajemajo celotno linijo proizvodov, za cepiva, pri katerih konvencionalne formulacije niso bile uspešne, pa so potrebni novi adjuvanti.
Access to vaccination must be widened and made easier to the recipient, particularly for vulnerable and underserved communities.
Povečati in olajšati je treba dostop do cepljenja, zlasti v ranljivih in manj pokritih skupnostih.
[18: Global Research Collaboration for Infectious Disease Preparedness https://www.glopid-r.org/]
[18: Globalno raziskovalno sodelovanje za pripravljenost na nalezljive bolezni, https://www.glopid-r.org/.]
As hesitancy differs across countries, populations and vaccines, having reliable stratified coverage data can help detecting sub-groups with lower uptake, assess the root-cause, and thus tailor the necessary intervention.
Ker se nezaupanje razlikuje po državah, prebivalstvu in glede na cepivo, lahko zanesljivi stratificirani podatki o precepljenosti pomagajo prepoznati podskupine z manjšo precepljenostjo, ovrednotiti temeljni vzrok za nezaupanje ter posledično prilagoditi potrebno posredovanje.
Effort is needed at EU and Member State level to develop operational guidelines and remove infrastructural, legal and standardisation barriers to facilitate interoperability and electronic data sharing in the area of vaccination, and harness the deployment of immunisation information systems to inform operational and strategic decisions.
Na evropski in nacionalni ravni si je treba prizadevati za pripravo operativnih smernic in odpravo infrastrukturnih, pravnih in standardizacijskih ovir, da se omogočita interoperabilnost in elektronska izmenjava podatkov na področju cepljenja ter izkoristi uvedba informacijskih sistemov za imunizacijo za poročanje o operativnih in strateških odločitvah.
There is value in better EU-coordinated efforts and pooling of joint EU technical expertise to assess the evidence in the pre- and post-licensing phase of a vaccine.
Smiselno je boljše usklajevanje prizadevanj na ravni EU ter združevanje skupnega evropskega tehničnega znanja za vrednotenje dokazov v obdobju pred izdajo dovoljenja za cepivo in po njem.
EU coordination and contribution to global health
STEBER III - Usklajevanje na evropski ravni in prispevanje k zdravju na svetovni ravni
Create a sustainable and multi-stakeholder platform for EU post-authorisation studies monitoring the safety, effectiveness, and impact of vaccination;
oblikovanje trajnostne platforme več zainteresiranih strani za evropske študije o spremljanju varnosti, učinkovitosti in vpliva cepljenja po izdaji dovoljenja;
Yet in spite of the overall benefits of vaccination, a number of key challenges still remain to ensure sustainable, equitable and effective vaccination programmes in all Member States, and to secure that the added benefits of vaccination are not lost.
Splošnim koristim cepljenja navkljub pa je za zagotovitev trajnostnih, enakih in učinkovitih programov cepljenja v vseh državah članicah ter za zagotovitev, da se dodatne koristi cepljenja ne izgubijo, treba premagati še več ključnih izzivov.
Mitigate risks of shortages by developing a virtual EU data warehouse on vaccine needs to facilitate voluntary exchange of information on available supplies and shortages of essential vaccines;
zmanjšanje tveganj pomanjkanja cepiv z razvojem virtualnega evropskega podatkovnega skladišča za beleženje potreb po cepivih, da se olajša prostovoljna izmenjava informacij o razpoložljivih zalogah in pomanjkanju osnovnih cepiv;
The most pressing challenges include overcoming vaccine hesitancy (the delay in acceptance or refusal of vaccines despite availability of vaccination services), halting the spread of vaccine preventable communicable diseases, sustaining high vaccine coverage, and guaranteeing equal access to vaccination across all ages and populations.
Najbolj pereči izzivi vključujejo odpravo nezaupanja v cepljenje (poznejša privolitev v cepljenje ali zavrnitev cepljenja kljub razpoložljivosti storitve), zaustavitev širjenja nalezljivih bolezni, ki jih je mogoče preprečiti s cepljenjem, ohranitev visoke stopnje precepljenosti in zagotavljanje enakega dostopa do cepljenja prebivalcem vseh starosti.
The financial sustainability of vaccination programmes is also key, to ensure stronger support to monitor the impact and effectiveness of vaccines, to mitigate the risk of shortages, and to tackle vaccine hesitancy and its impact on immunisation programmes.
Finančna vzdržnost programov cepljenja je prav tako ključna za zagotavljanje močnejše podpore spremljanju vpliva in učinkovitosti cepiv, zmanjševanje tveganj pomanjkanja cepiv in odpravljanje nezaupanja v cepljenje ter njegovega vpliva na programe imunizacije.